Filing Details
- Accession Number:
- 0000711377-17-000024
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-26 17:57:48
- Reporting Period:
- 2017-09-25
- Accepted Time:
- 2017-09-26 17:57:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1517426 | J. Steven Quinlan | 620 Lesher Place Lansing MI 48912 | Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-09-25 | 2,772 | $36.07 | 12,875 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-09-25 | 2,772 | $73.54 | 10,103 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock (Right to Buy) | Disposition | 2017-09-25 | 2,772 | $0.00 | 2,772 | $36.07 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
81,950 | 2018-08-30 | No | 4 | M | Direct |
Footnotes
- The options were granted on 8/30/2013, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant